Is a complete VIR research report available?

No complete published report is available for Vir Biotechnology, Inc. (VIR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Vir Biotechnology, Inc. (VIR)

NASDAQ: VIR · USD

$8.90

+0.26 (+3.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VIR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.5B
Revenue (ttm)	65.5M
Net income (ttm)	-442.7M
EPS (ttm)	-$3.14
Shares out	168.7M
Volume	1,197,340
Beta	1.62
Price target	$21.6	+142.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 65.5M
Net income (ttm): -442.7M
EPS (ttm): -$3.14
Market cap: 1.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All VIR indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001706431
Company name	Vir Biotechnology, Inc.
Country	United States
Country code	US
Cusip	92764N102
Employees	367
Employees Change	-41%
Employees Change Percent	-10.05
Enterprise value	$1.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-10-11
Isin	US92764N1028
Last refreshed	2026-07-31
Market cap	$1.5B
Market cap category	Small-Cap
Price	$8.9
Price currency	USD
Rev Per Employee	178,460.49x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2836
Symbol	VIR
Website	https://www.vir.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.49%
EV Sales Forward	4.35x
EV/Sales	17.1x
FCF yield	-29.96%
P/B ratio	1.77x
P/S ratio	22.92x
PS Forward	5.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-720.73%
EBITDA Margin	-702.99%
Gross Profit	$-371.2M
Net Income	$-442.7M
Net Income Growth Years	2%
Pretax Margin	-675.39%
Profit Per Employee	$-1.2M
ROA	-24.79
Roa5y	-4.38
ROCE	-49.58
ROE	-47.69
Roe5y	-7.75
ROIC	-111.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	69.59%
Cagr3y	-14.3%
Cagr5y	-24.55%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	213.96x
Revenue Growth Years	0x
Revenue Growth3 Y	-47.25x
Revenue Growth5 Y	-2.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.06
Assets	$1B
Cash	$476.3M
Current Assets	$523M
Current Liabilities	$73.6M
Debt	$95.6M
Debt Equity	$0.12
Equity	$812.8M
Liabilities	$212.8M
Long Term Assets	$502.6M
Long Term Liabilities	$139.3M
Net Cash	$380.7M
Net Cash By Market Cap	$25.36
Net Cash Growth	-46.04%
Net Debt Equity	$-0.47
Tangible Book Value	$788.1M
Tangible Book Value Per Share	$4.89
WACC	12.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.11
Net Working Capital	$-17.9M
Quick ratio	6.52
Working Capital	$449.4M
Working Capital Turnover	$0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.07%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	69.52%
200-day SMA	8.05
3Y total return	-37.06%
50-day SMA	9.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-75.54%
All Time High	141
All Time High Change	-93.69%
All Time High Date	2021-01-27
All Time Low	4.16
All Time Low Change	114.2%
All Time Low Date	2025-08-11
ATR	0.45
Beta	1.62
Beta1y	1.07
Beta2y	0.75
Ch YTD	47.6
High	9
High52	11.66
High52 Date	2026-04-20
High52ch	-23.67%
Low	8.61
Low52	4.16
Low52 Date	2025-08-11
Low52ch	114.2%
Ma50ch	-4.34%
Price vs 200-day SMA	10.55%
RSI	42.21
RSI Monthly	48.65
RSI Weekly	51.87
Sharpe ratio	1.04x
Sortino ratio	1.87
Total Return	-3.07%
Tr YTD	47.6
Tr1m	-14.26%
Tr1w	-4.71%
Tr3m	-11.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	8
Analyst Price Target Top	$20.29
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.88
Earnings Revenue Estimate	229,724,000x
Earnings Revenue Estimate Growth	18,822.9x
Operating Income	$-462.7M
Operating margin	-706.4
Price target	$21.56
Price Target Change	$142
Price Target Change Top	$128

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	128,761,486%
Float Percent	76.35%
Shares Insiders	4.4%
Shares Institutions	64.91%
Shares Out	168,651,974
Shares Qo Q	5.84%
Shares Yo Y	3.07%
Short Float	14.33%
Short Ratio	7.83
Short Shares	10.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-496.7M
Adjusted OCF	-493,151,000
Average Volume	1,574,909.4x
Bv Per Share	5.04
CAPEX	$-3.6M
Ch1m	-14.26
Ch1w	-4.71
Ch1y	69.52
Ch3m	-11.71
Ch3y	-37.06
Ch5y	-75.54
Ch6m	14.4
Change	3.01%
Change From Open	3.37
Close	8.64
Days Gap	-0.35
Depreciation Amortization	11,624,000
Dollar Volume	10,656,326
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-472M
EBITDA	$-460.4M
EPS	$-3.14
F Score	3
FCF	$-449.6M
FCF EV Yield	-40.14x
FCF Per Share	$-2.67
Financing CF	165,710,000
Fiscal Year End	December
Founded	2,016
Goodwill	16,937,000
Income Tax	$371,000
Investing CF	195,388,000
Ipr	-55.5
Iprfo	-44.89
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-23
Ma150	8.74
Ma150ch	1.81%
Ma20	9.5
Ma20ch	-6.27%
Net CF	-84,953,000
Next Earnings Date	2026-08-05
Open	8.61
Optionable	Yes
Position In Range	74.36
Post Close	8.9
Postmarket Change Percent	-1.91
Postmarket Price	$8.73
Ppne	113,918,000
Price Date	2026-07-30
Ptbv Ratio	1.9
Relative Volume	0.76x
Revenue	65,495,000x
SBC By Revenue	71.91x
Share Based Comp	47,100,000
Tax By Revenue	0.57x
Tr6m	14.4%
Us State	California
Volume	1,197,340
Z Score	-0.28

Vir Biotechnology, Inc. (VIR)

Coverage state: Market snapshot only — no published research

Generate the first VIR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · VIR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on VIR

Frequently asked questions